Wellgistics Health Inc. (WGRX)
Wellgistics Health Statistics
Share Statistics
Wellgistics Health has 51.94M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 51.94M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 14.85K |
| FTD / Avg. Volume | 8.55% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Wellgistics Health's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Wellgistics Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.4, with a Debt / Equity ratio of 3.73.
| Current Ratio | 0.4 |
| Quick Ratio | 0.15 |
| Debt / Equity | 3.73 |
| Debt / EBITDA | -5.11 |
| Debt / FCF | -15.67 |
| Interest Coverage | -7.39 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $584.8K |
| Profits Per Employee | $-221.17K |
| Employee Count | 31 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.72 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so Wellgistics Health's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | null |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 55.49 |
| Average Volume (20 Days) | 173.73K |
Income Statement
In the last 12 months, Wellgistics Health had revenue of 18.13M and earned -6.86M in profits. Earnings per share was 0.
| Revenue | 18.13M |
| Gross Profit | 1.77M |
| Operating Income | -6.15M |
| Net Income | -6.86M |
| EBITDA | -4.91M |
| EBIT | -6.02M |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 1.03M in cash and 25.11M in debt, giving a net cash position of -24.08M.
| Cash & Cash Equivalents | 1.03M |
| Total Debt | 25.11M |
| Net Cash | -24.08M |
| Retained Earnings | -9.76M |
| Total Assets | 57.33M |
| Working Capital | -22.88M |
Cash Flow
In the last 12 months, operating cash flow was -1.22M and capital expenditures -377.29K, giving a free cash flow of -1.6M.
| Operating Cash Flow | -1.22M |
| Capital Expenditures | -377.29K |
| Free Cash Flow | -1.6M |
| FCF Per Share | 0 |
Margins
Gross margin is 9.75%, with operating and profit margins of -33.9% and -37.82%.
| Gross Margin | 9.75% |
| Operating Margin | -33.9% |
| Pretax Margin | -37.82% |
| Profit Margin | -37.82% |
| EBITDA Margin | -27.08% |
| EBIT Margin | -33.9% |
| FCF Margin | -8.84% |
Dividends & Yields
WGRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for WGRX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.35 |
| Piotroski F-Score | 2 |